Affordable Access

Publisher Website

Myocardial regeneration with stem cells: Pharmacological possibilities for efficacy enhancement

Authors
Publisher
Elsevier Ltd
Publication Date
Volume
53
Issue
4
Identifiers
DOI: 10.1016/j.phrs.2006.01.009
Keywords
  • Heart Failure
  • Ischaemia
  • Myocardium
  • Regeneration
  • Stem Cell
  • Pharmacology
Disciplines
  • Biology
  • Medicine
  • Pharmacology

Abstract

Abstract Cell therapy through the application of stem or progenitor cells to regenerate and repair damaged myocardium has gone from the bench to clinical trial. The functional benefits observed in clinical trials are, however, moderate, and many challenges need to be overcome before cell therapy can be put into widespread clinical use. Better understanding of the signals and molecules that promote cell proliferation, differentiation, engraftment and survival may lead to development of pharmacological agents that enhance the capacity of stem/progenitor cells for myocardial regeneration. The present review will provide a critical analysis of the merits and limitations of different populations of stem/progenitor cells and discuss the potential of pharmacological strategies for enhancing the efficacy of cell therapy for myocardial regeneration.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Myocardial regeneration with stem cells: pharmacol...

on Pharmacological research April 2006

Enhancement of in vivo bone regeneration efficacy...

on Journal of microbiology and bi... May 2008

Enhancement of in vivo bone regeneration efficacy...

on Journal of Biomedical Material... May 2010

Myocardial regeneration by adult stem cells.

on The Israel Medical Association... April 2006
More articles like this..